ivan health semaglutide #glp1 #alcoholusedisorder #addictionmedicine #obesity #clinicalresearch #evidencebasedmedicine #metabolichealth #medicine #healthcareinnovation Week 2 on Semaglutide: Injection

Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis

In neurodegeneration, mitochondrial dysfunction, NOX activity and impaired mitophagy foster protein/lipid oxidation, ONOO -driven nitration and iron-sensitized lipid peroxidation (Ischiropoulos and Beckman 2003)

Animal studies have raised further red flags

Flow Wellness believes patient education is essential and works closely with patients to ensure they understand exactly what they are taking and how to take it correctly

doi:10.3389/fendo.2021.630504

Extra Travel Tips Carry a small cold pack or request one from flight staff if weather conditions get extreme